Versacross Large Access Solution
Payments companies reported to CMS as associated with Versacross Large Access Solution. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Versacross Large Access Solution, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Versacross Large Access Solution
These are the largest totals companies reported as associated with Versacross Large Access Solution. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Augustin Delago | Albany, NY | Cardiovascular Disease | $26,273.31 |
| Sunil Kapur | Boston, MA | Cardiovascular Disease | $14,571.60 |
| Patricia Tung | Boston, MA | Clinical Cardiac Electrophysiology | $9,387.00 |
| Jonathan Silver | Burlington, MA | Clinical Cardiac Electrophysiology | $8,750.00 |
| William Hucker | Boston, MA | Internal Medicine | $5,625.00 |
| Joseph Aragon | Santa Barbara, CA | Interventional Cardiology | $4,375.00 |
| Devi Nair | Jonesboro, AR | Clinical Cardiac Electrophysiology | $4,375.00 |
| Chad Kliger | New York, NY | Internal Medicine | $1,250.00 |
| Montoya Taylor | Milwaukee, WI | Interventional Cardiology | $1,026.73 |
| Muhammad Akbar | Bowling Green, KY | Cardiovascular Disease | $247.02 |
Prescribed Versacross Large Access Solution?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.